Multiple Choice
Medium-chain acyl-CoA dehydrogenase (MCAD) is an enzyme involved in β-oxidation, and is encoded by the autosomal ACADM gene. MCAD deficiency is caused by a mutation in ACADM, and results in impaired ability to digest medium-chain fatty acids for energy, and in their subsequent accumulation. Which of the following interventions would best relieve the negative effects of MCAD deficiency?
A) Mitochondrial gene therapy
B) Supplementation with long-chain fatty acids
C) Prolonged periods of fasting
D) A diet rich in glucose
Correct Answer:
Verified
Correct Answer:
Verified
Q238: Which amino acid substitution would result in
Q239: Which series depicts the order in which
Q240: Passage<br>Dystroglycan (Dg) is a transmembrane protein that
Q241: Which two enzymes of the pentose phosphate
Q242: Passage<br>Leptin signaling is vital for maintaining adequate
Q244: If a stretch of double-stranded DNA has
Q245: Passage<br>Glycolysis and gluconeogenesis are tightly regulated, opposing
Q246: The electron transport chain results in the
Q247: Passage<br>The cystic fibrosis transmembrane conductance regulator (CFTR)
Q248: A protein consisting of domains A, B,